You are currently browsing:

Breast Cancer Ireland Vacancy

Campaign Manager – Breast Cancer Ireland Breast Cancer Ireland is a registered charity established to raise funding to support pioneering research into breast cancer and to provide education and awareness on the importance of good breast health amongst women of all ages. Our vision is through increased speed of research discovery, which will transform breast […]

Read More

Pioneering Irish Research in Primary and Advanced Breast Cancer

Worldwide, 1.7 million women face a diagnosis of breast cancer each year – 460,000 are in the EU and 3,100 are in Ireland.  To mark World Cancer Day on Tuesday, February 4, 2020, Breast Cancer Ireland (BCI) announce new ground-breaking developments in so-called ‘personalised medicine’ or ‘precision medicine’, which is the tailoring of treatment strategies […]

Read More

How the Oncotype DX test could help you make a more informed treatment decision

The results of the Oncotype DX test, combined with other features of the specific cancer, can help you make a more informed decision regarding treatment. To those eligible, this test can provide new information that will help you decide whether or not to have chemotherapy to treat early-stage, hormone-receptor-positive breast cancer. It can also be […]

Read More

Drug that prevents half of breast cancers carries on working

A drug that halves a woman’s risk of breast cancer continues to work long after they stop taking it, say researchers. The drug, Anastrozole, blocks the production of the hormone oestrogen, which fuels the growth of many breast cancers. It halves the risk of breast cancer during the first five years. Now, however, trials on […]

Read More

Blood test may predict risk of recurrence for breast cancer patients

A special blood test may one day predict if a newly diagnosed breast cancer patient is likely to relapse years later, a City of Hope study suggests. “When patients are first diagnosed with cancer,” says Peter P. Lee, M.D., “it is important to identify those at higher risk for relapse for more aggressive treatments and […]

Read More
X